Astellas/Transplant Research Foundation of BC Clinical Research Grant 2016: Letter of Intent

Astellas Pharma Canada, Inc. (“Astellas”) and TRF are excited to announce the Astellas/Transplant Research Foundation of BC Clinical Research Grant Program Letter of Intent.

Program Description

This Grant Program aims to support investigator‐initiated, collaborative research in the transplant field. The objective of the Astellas/Transplant Research Foundation of BC Clinical Research Grant Program is to support peer-reviewed, patient-focused clinical research that addresses barriers in the field of transplant. Grant recipients are expected to demonstrate that their proposed research will improve knowledge in a scientific area relevant to organ donation or transplantation and/or contribute to improving patient care on a national scope.

A keyaspect of the Program is to further develop collaborative and multi‐disciplinary approaches to transplantation research in British Columbia and across Canada.

Eligibility

The successful applicant(s) must:

• Be a clinician or allied health professional (MD, Nurse, Social Worker, Pharmacist, transplant coordinator, etc.) actively involved in the field of solid organ transplantation.
• The nominated principal investigator (PI) must have an Appointment at a BC accredited University. This can be Clinical or Academic, but not at the Level of Full Professor to insure that junior faculty are awarded this opportunity.
• If a full professor is on the grant proposal team as a collaborator, the project must clearly be the work and ideas of the PI.
• If successful, agree to have their protocol shared with Astellas for internal or documentation and auditing purposes only.
• Agree to provide a progress report, including publication plan, to the TRFBC for dissemination of study results.

The research proposals being considered will be those addressing the broad area of patient‐focused, clinical research and/or translational research related to solid organ transplantation. Bench research will not be considered. Patient level research data must be part of the core project.

Collaborative projects between individuals with different expertise, and between institutions, are highly encouraged. Grant applications will be ranked on scientific merit. In the event of equally ranked grants, the application with greater collaborative activity will be funded.

Application Deadlines

Letter of Intent (LOI) forms are to be submitted on or before February 15, 2016. Only selected applicants will be invited to submit a full application. Full applications must be submitted by May 1, 2016. Funding decisions will be made on or before July 1, 2016. Successful applicants will be notified by email.

Funding

Grants will be awarded to the successful applicants. It is anticipated that two grants of $50,000 will be awarded in the 2016.

Full details

More information can be found at here: http://bit.ly/23vVw4Q